tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RZLT Stock Latest News

Rezolute Highlights Promising Phase 2 Ersodetug Results
Company AnnouncementsRezolute Highlights Promising Phase 2 Ersodetug Results
17d ago
8K
RZLT
Rezolute Gains FDA Breakthrough Designation for Ersodetug
PremiumCompany Announcements
Rezolute Gains FDA Breakthrough Designation for Ersodetug
24d ago
8K
RZLT
Rezolute receives BTD from FDA for ersodetug in treatment of hypoglycemia
PremiumThe Fly
Rezolute receives BTD from FDA for ersodetug in treatment of hypoglycemia
24d ago
RZLT
Rezolute reports inducement award under Nasdaq listing rule
PremiumThe Fly
Rezolute reports inducement award under Nasdaq listing rule
2M ago
RZLT
Rezolute announces U.S. FDA granted ODD to ersodetug
PremiumThe Fly
Rezolute announces U.S. FDA granted ODD to ersodetug
2M ago
RZLT
Rezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies
PremiumCompany AnnouncementsRezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies
2M ago
RZLT
Rezolute granted FDA orphan designation for treatment of hypoglycemia
Premium
The Fly
Rezolute granted FDA orphan designation for treatment of hypoglycemia
2M ago
RZLT
Rezolute price target raised to $8 from $7 at JMP Securities
Premium
The Fly
Rezolute price target raised to $8 from $7 at JMP Securities
3M ago
RZLT
Rezolute reports Q1 EPS (22c), consensus (33c)
PremiumThe Fly
Rezolute reports Q1 EPS (22c), consensus (33c)
3M ago
RZLT
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
RZLT
Rezolute initiated with an Outperform at Wedbush
PremiumThe Fly
Rezolute initiated with an Outperform at Wedbush
3M ago
RZLT
Rezolute initiated with an Outperform at Wedbush
PremiumThe Fly
Rezolute initiated with an Outperform at Wedbush
3M ago
RZLT
Rezolute reports Q4 EPS (44c), consensus (33c)
PremiumThe FlyRezolute reports Q4 EPS (44c), consensus (33c)
4M ago
RZLT
Rezolute management to meet with Maxim Group
Premium
The Fly
Rezolute management to meet with Maxim Group
4M ago
RZLT
RZLT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RZLT Earnings this Week: How Will it Perform?
5M ago
RZLT
Rezolute clinical hold removal ‘best case scenario,’ says H.C. Wainwright
PremiumThe Fly
Rezolute clinical hold removal ‘best case scenario,’ says H.C. Wainwright
5M ago
RZLT
‘Major overhang lifted’ on Rezolute, says Craig-Hallum
PremiumThe Fly
‘Major overhang lifted’ on Rezolute, says Craig-Hallum
5M ago
RZLT
Rezolute’s RZ358 Advances with FDA Clearance for Study
PremiumCompany Announcements
Rezolute’s RZ358 Advances with FDA Clearance for Study
5M ago
8K
RZLT
FDA lifts partial clinical holds on Rezolute’s RZ358
PremiumThe Fly
FDA lifts partial clinical holds on Rezolute’s RZ358
5M ago
RZLT
Rezolute initiated with a Buy at Guggenheim on potential in CHI
PremiumThe FlyRezolute initiated with a Buy at Guggenheim on potential in CHI
5M ago
RZLT
Rezolute initiated with a Buy at Guggenheim
Premium
The Fly
Rezolute initiated with a Buy at Guggenheim
5M ago
RZLT
Rezolute price target raised to $10 from $8 at Maxim
Premium
The Fly
Rezolute price target raised to $10 from $8 at Maxim
6M ago
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >